Antitumor effect of α-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3380-3387

  Fuji, Nobuaki ^a   Ueda, Yuji ^a   Fujiwara, Hitoshi ^a   Itoh, Tsuyoshi ^a   Yoshimura, Tetsunori ^a   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; MONOCLONAL ANTIBODY;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CYTOKINE PRODUCTION; CYTOTOXICITY; IMMUNOTHERAPY; LIVER METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GALACTOSYLCERAMIDES; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; LYMPH NODES; LYMPHOCYTES; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; SARCOMA, EXPERIMENTAL; SPLEEN;

EID: 0033871088     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vahrmeijer, A. L., van Dierendonck, J. H., and van de Velde, C. J. H. Treatment of colorectal cancer metastases confined to the liver. Eur. J. Cancer, 31A: 1238-1242, 1995.
2. Welch, J. P., and Donaldson, G. A. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann. Surg., 189: 496-502, 1979.
3. Morita, M., Motoki, K., Akimoto, K., Natori, T., Sakai, T., Sawa, E., Yamaji, K., Koezuka, Y., Kobayashi, E., and Fukushima, H. Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J. Med. Chem., 38: 2176-2187, 1995.
4. Kobayashi, E., Motoki, K., Uchida, T., Fukushima, H., and Koezuka, Y. KRN7000. A novel immunomodulator and its antitumor activities. Oncol. Res., 7: 529-534, 1995.
5. Yamaguchi, Y., Motoki, K., Ueno, H., Maeda, K., Kobayashi, E., Inoue, H., Fukushima, H., and Koezuka, Y. Enhancing effects of (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-2-(N-hexacosanoylamino)-1,3,4- octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells. Oncol. Res., 8: 399-407, 1996.
6. + progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1 (27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors. Cancer Res., 57: 5534-5541, 1997.
7. Probst, P., Skeiky, Y. A., Steeves, M., Gervassi, A., Grabstein, K. H., and Reed, S. G. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-α production and expression of B7-1 in human monocyte-derived antigen-presenting cells. Eur. J. Immunol., 27: 2634-2642, 1997.
8. Nakagawa, R., Motoki, K., Ueno, H., Iijima, R., Nakamura, H., Kobayashi, E., Shimosaka, A., and Koezuka, Y. Treatment of hepatic metastasis of the Colon26 adenocarcinoma with an α-galactosylceramide, KRN7000. Cancer Res., 58: 1202-1207, 1998.
9. Hart, I. R., Talmadge, J. E., and Fidler, I. J. Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth. Cancer Res., 41: 1281-1287, 1981.
10. Acerbis, G., Cleris, L., Rodolfo, M., Parmiani, G., and Formelli, F. Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosurea on spontaneous metastases of a non-immunogenic murine tumor. Cancer Immunol. Immunother., 34: 383-388, 1992.
11. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J. Immunol., 156: 3366-3373, 1996.
12. Watanabe, H., Ohtsuka, K., Kimura, M., Ikarashi, Y., Ohmori, K., Kusumi, A., Ohteki, T., Seki, S., and Abo, T. Details of an isolation method for hepatic lymphocytes in mice. J. Immunol. Methods, 146: 145-154, 1992.
13. Engwerda, C. R., Murphy, M. L., Cotterell, S. E. J., Smelt, S. C., and Kaye, P. M. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Eur. J. Immunol., 28: 669-680, 1998.
14. α14 NKT cells by glycosylceramides. Science (Washington DC), 278: 1626-1629, 1997.
15. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., Tanaka, Y., and Taniguchi, M. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc. Natl. Acad. Sci. USA, 95: 5690-5693, 1998.
16. Kitamura, H., Iwakabe, K., Yahata, T., Nishimura, S., Ohta, A., Ohmi, Y., Sato, M., Takeda, K., Okumura, K., Kaer, L. V., Kawano, T., Taniguchi, M., and Nishimura, T. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med., 189: 1121-1127, 1999.
17. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J. Immunol., 754: 4333-4340, 1995.
18. Lu, L., Woo, J., Rao, A. S., Li, Y., Watkins, S. C., Qian, S., Starzl, T. E., Demetris, A. J., and Thomson, A. W. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J. Exp. Med., 179: 1823-1834, 1994.
19. Drakes, M. L., Lu, L., Subbotin, V. M., and Thomson, A. W. In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver. J. Immunol., 159: 4268-4278, 1997.
20. α14 NKT cells in IL-12-mediated rejection of tumors. Science (Washington DC), 278: 1623-1626, 1997.
21. Péron, J-M., Esche, C., Subbotin, V. M., Maliszewski, C., Lotze, M. T., and Shurin, M. R. FLT3-ligand administration inhibits liver metastases: role of NK cells. J. Immunol., 161: 6164-6170, 1998.
22. + αβ T cells in the lungs of euthymic and athymic mice. Immunology, 88: 82-89, 1996.
23. Voest, E. E., Kenyon, B. M., O'Reilly, M. S., Truitt, G., D'Amato, R. J., and Folkman, J. Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst., 87: 581-586, 1995.
24. Brossay, L., Chioda, M., Burdin, N., Koezuka, Y., Casorad, G., Dellabona, P., and Kronenberg, M. CD Id-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med., 188: 1521-1528, 1998.
25. Spada, F. M., Koezuka, Y., and Porcelli, S. A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med., 188: 1529-1534, 1998.